Recent advances in the ARID family: focusing on roles in human cancer

The human AT-rich interaction domain (ARID) family contains seven subfamilies and 15 members characterized by having an ARID. Members of the ARID family have the ability to regulate transcription and are involved in cell differentiation and proliferation. Accumulating evidence suggests that ARID family members are involved in cancer-related signaling pathways, highly mutated or differentially expressed in tumor tissues, and act as predictive factors for cancer prognosis or therapeutic outcome. Here we review the molecular biology and clinical studies concerned with the role played by the ARID family in cancer. This may contribute to our understanding of the initiation and progression of cancer from a novel point of view, as well as providing potential targets for cancer therapy.

[1]  A. Giuliano,et al.  Recognition of an epitope of a breast cancer antigen by human antibody , 1999, Breast Cancer Research and Treatment.

[2]  A. Veronese,et al.  Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene , 2006, Genes, chromosomes & cancer.

[3]  P. Dallas,et al.  Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. , 2004, The Biochemical journal.

[4]  M. Meyerson,et al.  Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1 , 2011, Proceedings of the National Academy of Sciences.

[5]  D. Leprince,et al.  HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. , 2009, Biochemical and biophysical research communications.

[6]  Y F Lau,et al.  Expression analysis of thirty one Y chromosome genes in human prostate cancer , 2000, Molecular carcinogenesis.

[7]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[8]  Franz Oswald,et al.  Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex. , 2010, Genes & development.

[9]  S. Ichwan,et al.  E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. , 2003, Molecular cancer research : MCR.

[10]  M. Landthaler,et al.  Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas , 2005, Modern Pathology.

[11]  M. Loh,et al.  ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Saint,et al.  ARID proteins come in from the desert. , 2000, Trends in biochemical sciences.

[13]  R. Young,et al.  Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. , 2005, Molecular cell.

[14]  E. Li,et al.  Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma. , 2013, Acta histochemica.

[15]  D. Tyrrell,et al.  IFITM1 is a tight junction protein that inhibits hepatitis C virus entry†, ‡ , 2012, Hepatology.

[16]  K. Pan,et al.  Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer , 2012, PloS one.

[17]  D. Hémon,et al.  Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)? , 2013, Leukemia.

[18]  Peer Bork,et al.  SMART 7: recent updates to the protein domain annotation resource , 2011, Nucleic Acids Res..

[19]  E. Stanbridge,et al.  RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis. , 2001, Journal of the National Cancer Institute.

[20]  Tian-Li Wang,et al.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. , 2011, Cancer research.

[21]  S. Nishikawa,et al.  Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn , 2012, Oncogene.

[22]  M. Toyoda,et al.  Jumonji is a nuclear protein that participates in the negative regulation of cell growth. , 2000, Biochemical and biophysical research communications.

[23]  Y. Shinkai,et al.  A Jumonji (Jarid2) Protein Complex Represses cyclin D1 Expression by Methylation of Histone H3-K9* , 2009, Journal of Biological Chemistry.

[24]  Xiaomei Wang,et al.  Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control , 2007, The EMBO journal.

[25]  Y. Tsunematsu,et al.  E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies , 2004, Cell Death and Differentiation.

[26]  T. Pawlik,et al.  Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas , 2013, Nature Genetics.

[27]  Dinshaw J. Patel,et al.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger , 2009, Nature.

[28]  M. Relling,et al.  ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence , 2010, Leukemia.

[29]  B. Ponder,et al.  Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway , 2010, Molecular Cancer.

[30]  Karen D. Cowden Dahl,et al.  The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. , 2009, Neoplasia.

[31]  L. Robison,et al.  ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2013, Leukemia research.

[32]  Alan J. Tackett,et al.  Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen* , 2013, The Journal of Biological Chemistry.

[33]  D. Reinberg,et al.  RBP1 Recruits the mSIN3-Histone Deacetylase Complex to the Pocket of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited Discrete Regions of the Nucleus at Growth Arrest , 2001, Molecular and Cellular Biology.

[34]  J. Taylor‐Papadimitriou,et al.  Functional Analysis of the Transcription Supplemental Material , 2007 .

[35]  J. Workman,et al.  Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription* , 2004, Journal of Biological Chemistry.

[36]  Michael Landthaler,et al.  RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells , 2007, International journal of cancer.

[37]  C. Chen,et al.  JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[38]  S. Perrett,et al.  Structural Insight into Recognition of Methylated Histone Tails by Retinoblastoma-binding Protein 1* , 2012, The Journal of Biological Chemistry.

[39]  M. Landthaler,et al.  Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. , 2006, The Journal of investigative dermatology.

[40]  B. Garcia,et al.  H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence , 2012, Proceedings of the National Academy of Sciences.

[41]  R. Bernards,et al.  The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence , 2011, PloS one.

[42]  P. Dallas,et al.  ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[43]  A. E. Erson-Bensan,et al.  miR-125b targets ARID3B in breast cancer cells. , 2012, Cell structure and function.

[44]  K. Kalland,et al.  ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas , 2013, Modern Pathology.

[45]  Danny R. Welch,et al.  Allelic Variation and Differential Expression of the mSIN3A Histone Deacetylase Complex Gene Arid4b Promote Mammary Tumor Growth and Metastasis , 2012, PLoS genetics.

[46]  E. Moran,et al.  Nomenclature of the ARID family of DNA-binding proteins. , 2005, Genomics.

[47]  S. Meier-Ewert,et al.  A Novel Gene (PLU-1) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer* , 1999, The Journal of Biological Chemistry.

[48]  I. Shih,et al.  Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma , 2012, International Journal of Gynecologic Cancer.

[49]  A. Agulnik,et al.  Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. , 1995, Science.

[50]  C. Croce,et al.  Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. , 1999, Cancer research.

[51]  M. Zhou,et al.  The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C , 2012, Oncogene.

[52]  H. Kiyonari,et al.  Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo , 2013, Proceedings of the National Academy of Sciences.

[53]  C. Liu,et al.  Chromatin remodeling: recruitment of histone demethylase RBP2 by Madl for transcriptional repression of a Myc target gene, telomerase reverse transcriptase , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  Giovanni Parmigiani,et al.  Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.

[55]  Arthur L. Beaudet,et al.  Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes , 2008, Journal of the National Cancer Institute.

[56]  K. Itakura,et al.  Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. , 1996, Nucleic acids research.

[57]  J. Qin,et al.  Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms , 2011, PloS one.

[58]  Yi-Chun Chen,et al.  The JmjN Domain of Jhd2 Is Important for Its Protein Stability, and the Plant Homeodomain (PHD) Finger Mediates Its Chromatin Association Independent of H3K4 Methylation*♦ , 2010, The Journal of Biological Chemistry.

[59]  Wayne Tam,et al.  Reticuloendotheliosis Virus Strain T Induces miR-155, Which Targets JARID2 and Promotes Cell Survival , 2009, Journal of Virology.

[60]  T. Pandita,et al.  E2FBP1 antagonizes the p16INK4A-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability , 2011, International Journal of Oral Science.

[61]  Arnaud Pigneux,et al.  Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study , 2012, British journal of haematology.

[62]  C. Webb,et al.  Loss of Bright/ARID3a Function Promotes Developmental Plasticity , 2010, Stem cells.

[63]  Keith A. Boroevich,et al.  Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.

[64]  Kairong Cui,et al.  PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. , 2005, Genes & development.

[65]  Michael A Choti,et al.  Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma , 2011, Nature Genetics.

[66]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[67]  R. Stevenson,et al.  Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia , 2008, Journal of Medical Genetics.

[68]  K. Helin,et al.  RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3 , 2007, Cell.

[69]  C. Schmidt,et al.  Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription. , 2011, Molecular immunology.

[70]  Qin Lu,et al.  Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. , 2013, Gene.

[71]  Amanda J. Guise,et al.  The functional interactome landscape of the human histone deacetylase family , 2013, Molecular systems biology.

[72]  C. Webb,et al.  Expression of bright at two distinct stages of B lymphocyte development. , 1998, Journal of immunology.

[73]  H. Katagiri,et al.  Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma , 2012, Modern Pathology.

[74]  Ryuji Kobayashi,et al.  The Human SWI-SNF Complex Protein p270 Is an ARID Family Member with Non-Sequence-Specific DNA Binding Activity , 2000, Molecular and Cellular Biology.

[75]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[76]  M. Torbenson,et al.  ARID2: A new tumor suppressor gene in hepatocellular carcinoma , 2011, Oncotarget.

[77]  Huajian Gao,et al.  Characterization of BRCAA1 and its novel antigen epitope identification. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[78]  P. Brousset,et al.  B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells , 2012, Leukemia.

[79]  S. Ishikawa,et al.  ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability , 2012, Virchows Archiv.

[80]  Hans Clevers,et al.  Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. , 2002, The Biochemical journal.

[81]  C. Badenas,et al.  A novel mutation in JARID1C gene associated with mental retardation , 2006, European Journal of Human Genetics.

[82]  A. Noske,et al.  Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? , 2012, Modern Pathology.

[83]  E. Moran,et al.  DNA-binding properties of ARID family proteins , 2005, Nucleic acids research.

[84]  Maite Huarte,et al.  The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases , 2007, Cell.

[85]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[86]  Karen D. Cowden Dahl,et al.  ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death , 2012, PloS one.

[87]  Anjanabha Saha,et al.  ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression , 2006, Nature.

[88]  H. Ishii,et al.  Depletion of JARID1B induces cellular senescence in human colorectal cancer. , 2013, International journal of oncology.

[89]  B. Spencer‐Dene,et al.  PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. , 2011, International journal of oncology.

[90]  S Gowrishankar,et al.  ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines , 2013, British Journal of Cancer.

[91]  P. Dallas,et al.  Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors , 2004, International journal of cancer.

[92]  R. Clubb,et al.  Solution structure of the DNA binding domain from Dead ringer, a sequence‐specific AT‐rich interaction domain (ARID) , 1999, The EMBO journal.

[93]  W. Lestari,et al.  Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage. , 2012, Biochemical and biophysical research communications.

[94]  J. Gécz,et al.  Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. , 2005, American journal of human genetics.

[95]  T. Takeuchi,et al.  Roles of jumonji and jumonji family genes in chromatin regulation and development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[96]  H. Katagiri,et al.  Frequent Loss of Tumor Suppressor ARID1A Protein Expression in Adenocarcinomas/Adenosquamous Carcinomas of the Uterine Cervix , 2011, International Journal of Gynecologic Cancer.

[97]  S. Imbeaud,et al.  Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma , 2013, International journal of cancer.

[98]  Yi Zhang,et al.  New Nomenclature for Chromatin-Modifying Enzymes , 2007, Cell.

[99]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[100]  Meng Li,et al.  Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.

[101]  Ming Jiang,et al.  ARID4A and ARID4B regulate male fertility, a functional link to the AR and RB pathways , 2013, Proceedings of the National Academy of Sciences.

[102]  B. Gui,et al.  Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. , 2011, Cancer research.

[103]  P. Tonin,et al.  An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer , 2012, Oncogene.

[104]  Dongkyoon Kim,et al.  A Regulated Nucleocytoplasmic Shuttle Contributes to Bright's Function as a Transcriptional Activator of Immunoglobulin Genes , 2006, Molecular and Cellular Biology.

[105]  R. Janknecht,et al.  Repression of Smad3 activity by histone demethylase SMCX/JARID1C. , 2008, Biochemical and biophysical research communications.

[106]  P. Dallas,et al.  The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest. , 2005, Cancer research.

[107]  Tian-Li Wang,et al.  Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma , 2010, Science.

[108]  Alexander Roesch,et al.  A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.

[109]  M. Cazzola,et al.  Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies , 2012, American journal of hematology.

[110]  G. Daley,et al.  A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence , 2002, Nature Cell Biology.

[111]  Paul Tempst,et al.  PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. , 2007, Molecular cell.

[112]  Richard A. Moore,et al.  ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.

[113]  I. Shih,et al.  Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. , 2012, Neoplasia.